These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31646707)

  • 1. Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.
    Rachwan RJ; Butler J; Collins SP; Cotter G; Davison BA; Senger S; Ezekowitz JA; Filippatos G; Levy PD; Metra M; Ponikowski P; Teerlink JR; Voors AA; de Boer RA; Soergel DG; Felker GM; Pang PS
    Eur J Heart Fail; 2019 Dec; 21(12):1561-1570. PubMed ID: 31646707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?
    Cotter G; Metra M; Davison BA; Jondeau G; Cleland JGF; Bourge RC; Milo O; O'Connor CM; Parker JD; Torre-Amione G; van Veldhuisen DJ; Kobrin I; Rainisio M; Senger S; Edwards C; McMurray JJV; Teerlink JR;
    Eur J Heart Fail; 2018 Feb; 20(2):317-322. PubMed ID: 28871621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.
    Muhlestein JB; May HT; Bair TL; Prescott MF; Horne BD; White R; Anderson JL
    Am J Cardiol; 2010 Sep; 106(6):764-9. PubMed ID: 20816114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.
    Vaduganathan M; Cheema B; Cleveland E; Sankar K; Subacius H; Fonarow GC; Solomon SD; Lewis EF; Greene SJ; Maggioni AP; Böhm M; Zannad F; Butler J; Gheorghiade M
    Eur J Heart Fail; 2018 Apr; 20(4):677-686. PubMed ID: 29143416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure.
    Morris AA; Nayak A; Ko YA; D'Souza M; Felker GM; Redfield MM; Tang WHW; Testani JM; Butler J
    Circ Heart Fail; 2020 Jul; 13(7):e006827. PubMed ID: 32635768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF).
    Grodin JL; Gallup D; Anstrom KJ; Felker GM; Chen HH; Tang WHW
    Am J Cardiol; 2017 Jun; 119(12):2003-2009. PubMed ID: 28433216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
    Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
    J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.
    Pang PS; Teerlink JR; Boer-Martins L; Gimpelewicz C; Davison BA; Wang Y; Voors AA; Severin T; Ponikowski P; Hua TA; Greenberg BH; Filippatos G; Felker GM; Cotter G; Metra M
    Am Heart J; 2017 May; 187():62-69. PubMed ID: 28454809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).
    Ambrosy AP; Bhatt AS; Gallup D; Anstrom KJ; Butler J; DeVore AD; Felker GM; Fudim M; Greene SJ; Hernandez AF; Kelly JP; Samsky MD; Mentz RJ
    Am J Cardiol; 2017 Jul; 120(1):98-105. PubMed ID: 28479167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
    Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
    Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.
    Cotter G; Davison BA; Butler J; Collins SP; Ezekowitz JA; Felker GM; Filippatos G; Levy PD; Metra M; Ponikowski P; Teerlink JR; Voors AA; Senger S; Bharucha D; Goin K; Soergel DG; Pang PS
    Clin Res Cardiol; 2018 Feb; 107(2):170-181. PubMed ID: 28986703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.
    Cotter G; Metra M; Davison BA; Senger S; Bourge RC; Cleland JG; Jondeau G; Krum H; O'Connor CM; Parker JD; Torre-Amione G; van Veldhuisen DJ; Milo O; Kobrin I; Rainisio M; McMurray JJ; Teerlink JR;
    Eur J Heart Fail; 2014 Dec; 16(12):1362-71. PubMed ID: 25371147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
    Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
    Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(6):1307-14. PubMed ID: 25753468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
    Kelly JP; Mentz RJ; Hasselblad V; Ezekowitz JA; Armstrong PW; Zannad F; Felker GM; Califf RM; O'Connor CM; Hernandez AF
    Am Heart J; 2015 Aug; 170(2):298-305. PubMed ID: 26299227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
    Ng LL; Squire IB; Jones DJL; Cao TH; Chan DCS; Sandhu JK; Quinn PA; Davies JE; Struck J; Hartmann O; Bergmann A; Mebazaa A; Gayat E; Arrigo M; Akiyama E; Sabti Z; Lohrmann J; Twerenbold R; Herrmann T; Schumacher C; Kozhuharov N; Mueller C;
    J Am Coll Cardiol; 2017 Jan; 69(1):56-69. PubMed ID: 28057251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.